Cargando…

Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control

Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamlyn, John M., Linde, Cristina I., Gao, Junjie, Huang, Bing S., Golovina, Vera A., Blaustein, Mordecai P., Leenen, Frans H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183521/
https://www.ncbi.nlm.nih.gov/pubmed/25275393
http://dx.doi.org/10.1371/journal.pone.0108916
_version_ 1782337704220950528
author Hamlyn, John M.
Linde, Cristina I.
Gao, Junjie
Huang, Bing S.
Golovina, Vera A.
Blaustein, Mordecai P.
Leenen, Frans H. H.
author_facet Hamlyn, John M.
Linde, Cristina I.
Gao, Junjie
Huang, Bing S.
Golovina, Vera A.
Blaustein, Mordecai P.
Leenen, Frans H. H.
author_sort Hamlyn, John M.
collection PubMed
description Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained phase of hypertension is associated also with elevated circulating levels of endogenous ouabain (EO), and chronic stimulation of arterial calcium transport proteins including the sodium-calcium exchanger (NCX1), the type 6 canonical transient receptor potential protein (TRPC6), and the sarcoplasmic reticulum calcium ATPase (SERCA2). Wistar rats received a chronic intra-cerebroventricular infusion of vehicle (C) or Ang II (A, 2.5 ng/min, for 14 days) alone or combined with the MR blocker, eplerenone (A+E, 5 µg/day), or the aldosterone synthase inhibitor, FAD286 (A+F, 25 µg/day). Conscious mean BP increased (P<0.05) in A (123±4 mm Hg) vs all other groups. Blood, pituitary and adrenal samples were taken for EO radioimmunoassay (RIA), and aortas for NCX1, TRPC6 and SERCA2 immunoblotting. Central infusion of Ang II raised plasma EO (0.58±0.08 vs C 0.34±0.07 nM (P<0.05), but not in A + E and A + F groups as confirmed by off-line liquid chromatography (LC)-RIA and LC-multistage mass spectrometry. Two novel isomers of EO were elevated by Ang II; the second less polar isomer increased >50-fold in the A+F group. Central Ang II increased arterial expression of NCX1, TRPC6 and SERCA2 (2.6, 1.75 and 3.7-fold, respectively; P<0.01)) but not when co-infused with E or F. Adrenal and pituitary EO were unchanged. We conclude that brain Ang II activates a CNS-humoral axis involving plasma EO. The elevated EO reprograms peripheral ion transport pathways known to control arterial Na(+) and Ca(2+) homeostasis; this increases contractility and augments sympathetic effects. The new axis likely contributes to the chronic pressor effect of brain Ang II.
format Online
Article
Text
id pubmed-4183521
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41835212014-10-07 Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control Hamlyn, John M. Linde, Cristina I. Gao, Junjie Huang, Bing S. Golovina, Vera A. Blaustein, Mordecai P. Leenen, Frans H. H. PLoS One Research Article Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained phase of hypertension is associated also with elevated circulating levels of endogenous ouabain (EO), and chronic stimulation of arterial calcium transport proteins including the sodium-calcium exchanger (NCX1), the type 6 canonical transient receptor potential protein (TRPC6), and the sarcoplasmic reticulum calcium ATPase (SERCA2). Wistar rats received a chronic intra-cerebroventricular infusion of vehicle (C) or Ang II (A, 2.5 ng/min, for 14 days) alone or combined with the MR blocker, eplerenone (A+E, 5 µg/day), or the aldosterone synthase inhibitor, FAD286 (A+F, 25 µg/day). Conscious mean BP increased (P<0.05) in A (123±4 mm Hg) vs all other groups. Blood, pituitary and adrenal samples were taken for EO radioimmunoassay (RIA), and aortas for NCX1, TRPC6 and SERCA2 immunoblotting. Central infusion of Ang II raised plasma EO (0.58±0.08 vs C 0.34±0.07 nM (P<0.05), but not in A + E and A + F groups as confirmed by off-line liquid chromatography (LC)-RIA and LC-multistage mass spectrometry. Two novel isomers of EO were elevated by Ang II; the second less polar isomer increased >50-fold in the A+F group. Central Ang II increased arterial expression of NCX1, TRPC6 and SERCA2 (2.6, 1.75 and 3.7-fold, respectively; P<0.01)) but not when co-infused with E or F. Adrenal and pituitary EO were unchanged. We conclude that brain Ang II activates a CNS-humoral axis involving plasma EO. The elevated EO reprograms peripheral ion transport pathways known to control arterial Na(+) and Ca(2+) homeostasis; this increases contractility and augments sympathetic effects. The new axis likely contributes to the chronic pressor effect of brain Ang II. Public Library of Science 2014-10-02 /pmc/articles/PMC4183521/ /pubmed/25275393 http://dx.doi.org/10.1371/journal.pone.0108916 Text en © 2014 Hamlyn et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hamlyn, John M.
Linde, Cristina I.
Gao, Junjie
Huang, Bing S.
Golovina, Vera A.
Blaustein, Mordecai P.
Leenen, Frans H. H.
Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
title Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
title_full Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
title_fullStr Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
title_full_unstemmed Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
title_short Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
title_sort neuroendocrine humoral and vascular components in the pressor pathway for brain angiotensin ii: a new axis in long term blood pressure control
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183521/
https://www.ncbi.nlm.nih.gov/pubmed/25275393
http://dx.doi.org/10.1371/journal.pone.0108916
work_keys_str_mv AT hamlynjohnm neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol
AT lindecristinai neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol
AT gaojunjie neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol
AT huangbings neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol
AT golovinaveraa neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol
AT blausteinmordecaip neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol
AT leenenfranshh neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol